Amid rising HIV/AIDS cases, Meghalaya to mandate pre-marital testing, starting in East Khasi Hills, citing sexual ...

Last year, studies suggested that lenacapavir, already used to treat people with HIV, was nearly 100% effective in stopping ...

Once the regulator's guidance is accepted by the European Commission, the authorisation is valid in all 27 EU member countries as well as Iceland, Norway and Liechtenstein.

Needham has a $133 price target on the stock, representing an upside of about 17.5% to the stock’s closing price on Thursday.

A federal judge extended a block on an Idaho law that uses an applicant’s immigration status to determine whether they’re ...

The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV. Scientists say this ...

European regulators have greenlit a twice-yearly injection to prevent HIV that has been hailed as a game-changer in the ...

Researchers say findings point to gaps in prenatal HIV detection; the majority of infants not treated for HIV infection after birth were Black.

Gilead on Friday said the recommendation by the European Medicines Agency's Committee for Medicinal Products for Human Use covers lenacapavir for use as pre-exposure prophylaxis, or PrEP, to reduce ...

CEO Emma Walmsley’s 40-bln-pound 2031 sales target looks fanciful after another disappointing drug trial. A healthy balance ...

The European Union's drugs regulator has recommended approval of Gilead Sciences' lenacapavir, a twice-yearly injection, for ...